Signature Equity Partners’s Globus Medical GMED Stock Holding History

Signature Equity Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.98K	Buy	63 +61	+3,050%	+$5.18K	﹤0.01%	990
2026 Q1	$172	Sell	2 -2	-50%	-$180	﹤0.01%	1495
2025 Q4	$349	Buy	+4	New	+$304	﹤0.01%	1578

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Signature Equity Partners's GMED Position: Q2 2026 in Review

Signature Equity Partners increased its Globus Medical (GMED) stake by 3,050% in Q2 2026, buying an estimated $5.18K and bringing the position to 63 shares worth $4.98K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Signature Equity Partners first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Signature Equity Partners held 63 shares of Globus Medical worth $4.98K as of Q2 2026.
Signature Equity Partners bought 61 Globus Medical shares in Q2 2026, an estimated $5.18K.
Globus Medical made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #990 holding.
Signature Equity Partners first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.